CHS Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
CHS Bundle
Unlock the full strategic blueprint behind CHS’s business model and discover how it creates value across agriculture, energy, and trading. This in-depth Business Model Canvas breaks down customer segments, revenue streams, key partnerships, and cost drivers. Purchase the complete, editable canvas to benchmark, strategize, and apply CHS’s proven tactics to your own plans.
Partnerships
Affiliation agreements secure admitting, procedural coverage and call schedules, supporting systems where over 70% of physicians are hospital-employed; co-management or JV structures have improved orthopedic throughput and reduced length-of-stay by roughly 0.3–0.5 days in published analyses. Clinically aligned networks reduce referral leakage and standardize care pathways; recruitment pipelines help mitigate the AAMC-projected physician shortfall of up to 124,000 by 2034, crucial for non-urban markets.
Contracting with payors—Medicare (~65 million beneficiaries in 2024), Medicaid/CHIP (over 90 million combined in 2024) and commercial insurers—sets reimbursement rates and governs value-based incentives and bundled payments. Participation in government programs anchors volume and community access while risk-sharing arrangements tie material portions of revenue to quality and cost outcomes. Clearinghouse partners streamline electronic claims flow and denials management, shortening cash cycles.
EHR platforms enable documentation, coding and interoperability across facilities with certified EHR adoption at about 96% of US hospitals in 2024, supporting value-based care. Clinical decision support and telehealth tools extend specialist access—telehealth remains a meaningful channel post-pandemic. Cybersecurity partners mitigate PHI risk as average healthcare breach costs near $11.6M, ensuring regulatory compliance. Analytics vendors drive population health and revenue integrity, cutting readmissions by ~10–15% and improving billing recovery 3–5%.
Suppliers, GPOs, and device/pharma companies
GPO membership typically cuts unit costs for drugs, implants and supplies by about 7–12% (2024 industry averages), while strategic vendor ties secure availability for critical lines and reduce stockouts. Consigned inventory plus negotiated rebates improve working capital by lowering inventory carrying costs (~20%) and accelerating cash recovery. Pharmacy services enable 340B capture and formulary adherence, trimming drug spend and supporting margin.
- GPO savings: 7–12% (2024)
- Consigned inventory: ~20% lower carrying costs
- Rebates: faster cash recovery, improved WC
- Pharmacy: 340B capture, formulary adherence
Community, post-acute, and academic partners
Partnerships with rehab, SNFs, and home health streamline discharge workflows and lower 30-day readmissions by up to 25–30% through coordinated transitional care; roughly 1.3 million nursing home residents nationally highlight scale. Public health agencies enable coordinated outreach and preparedness, while academic links support residency rotations and talent pipelines; community groups address preventative care and social determinants, which drive up to 50% of health outcomes.
- Post-acute integration: smoother discharges, readmissions down 25–30%
- SNF scale: ~1.3 million nursing home residents
- Public health: coordinated outreach/preparedness
- Academic: residency rotations, workforce pipeline
- Community: prevention, social determinants support (≈50% impact)
Affiliation agreements secure coverage and workflows, with co-management/JV models cutting ortho LOS ~0.3–0.5 days and >70% hospital-employed physicians. Payor contracting (Medicare 65M, Medicaid/CHIP ~90M in 2024) governs reimbursement, VBC and risk-sharing. GPOs, EHRs (96% hospital adoption in 2024), suppliers and post-acute partners cut costs, reduce readmissions 25–30% and protect revenue.
| Partnership | Metric | 2024 Data |
|---|---|---|
| Medicare | Beneficiaries | 65M |
| Medicaid/CHIP | Enrollees | ~90M |
| GPO | Cost savings | 7–12% |
| EHR | Hospital adoption | 96% |
| Security | Breach cost | $11.6M |
| Post-acute | Readmission reduction | 25–30% |
What is included in the product
A comprehensive CHS Business Model Canvas detailing customer segments, value propositions, channels, revenue streams and key resources across the 9 classic BMC blocks, with competitive analysis, SWOT-linked insights and polished narrative ideal for presentations, investor review and strategic decision-making.
High-level, editable CHS Business Model Canvas that condenses strategy into a single page, saving hours of formatting and enabling quick comparison, collaboration, and fast executive deliverables.
Activities
Deliver inpatient, surgical, ED, and outpatient services across CHS's network of 79 hospitals and affiliated clinics, coordinating care across acute and ambulatory settings to support roughly 11,000 licensed beds (2024).
Standardize protocols for safety, quality, and throughput using evidence-based pathways and EMR-driven checklists to reduce variation and improve outcomes.
Optimize bed management, OR utilization, and care coordination to boost occupancy efficiency and elective surgery throughput while maintaining 24/7 critical services in target markets.
Revenue cycle management ensures accurate charge capture, compliant coding and submission of clean claims targeting a >95% clean-claim rate; industry denial rates averaged 6–8% in 2024. Robust denial management, AR follow-up and timely cash posting reduce Days in AR (median ~45–50 days) and maximize yield. Proactive eligibility checks and pre-authorizations cut write-offs, while monitoring payer mix and contract performance preserves margin and reimbursement optimization.
Recruit and retain clinicians through competitive pay, career pathways and culture initiatives across CHS’s network of about 84 hospitals, reducing turnover and credentialing lag. Manage staffing, scheduling and productivity for nurses and allied teams using centralized workforce platforms to optimize float pools and overtime. Provide CME and quality-based incentives tied to metrics like readmissions and HCAHPS, and close rural coverage gaps with telemedicine and locum tenens.
Quality, compliance, and risk management
CHS tracks core measures including HCAHPS and safety-event reductions, aligning with CMS value-based purchasing (adjusts roughly 2% of Medicare payments) and Joint Commission standards; HIPAA and state rules are enforced through policy and training. Internal audits drive corrective action plans; rigorous credentialing and malpractice management limit exposure and maintain Medicare participation.
- Track HCAHPS, core measures, safety events
- Compliance: HIPAA, CMS (VBP ~2%), Joint Commission, state
- Internal audits + corrective actions
- Malpractice exposure control & strict credentialing
Market development and service line growth
Scale high-acuity, high-margin lines—cardiology and orthopedics—while prioritizing physician outreach and referral-network growth; use 2024 market analytics showing ambulatory care now represents over 60% of outpatient encounters to target non-urban catchments; execute facility upgrades and strategic ambulatory site placement to capture unmet demand and improve EBITDA.
- Expand cardiology/orthopedics
- Physician outreach & referrals
- Data-driven non-urban demand ID
- Facility upgrades & ambulatory sites
Deliver inpatient, surgical, ED and outpatient care across CHS's 79 hospitals and affiliates, supporting ~11,000 licensed beds (2024).
Standardize protocols, optimize bed/OR use and care coordination to raise throughput and outcomes; ambulatory now >60% of encounters (2024).
Revenue cycle targets >95% clean-claim, denial rates 6–8%, Days in AR ~45–50; prioritize cardiology/orthopedics expansion and ambulatory sites.
| Metric | 2024 |
|---|---|
| Hospitals | 79 |
| Licensed beds | ~11,000 |
| Ambulatory % | >60% |
| Clean-claim target | >95% |
| Denial rate | 6–8% |
| Days in AR | 45–50 |
| Medicare VBP impact | ~2% |
Delivered as Displayed
Business Model Canvas
The CHS Business Model Canvas you’re previewing is the actual deliverable, not a mockup or sample. When you purchase, you’ll receive this same professional, fully editable document ready for use in Word and Excel. No hidden pages or altered content—what you see is what you’ll download and own.
Resources
Owned and leased acute care hospitals form CHS’s service backbone, aligning with the US hospital base of roughly 6,000 facilities; outpatient centers, imaging suites and ambulatory surgery centers extend access and lower unit costs. EDs and urgent care sites capture unscheduled demand amid ~130 million annual US ED visits (2023–24). Physical plant capabilities determine bed capacity, OR supply and resultant case mix, driving utilization and reimbursement mix.
Employed and affiliated physicians anchor CHS specialty coverage, leveraging a national pool of over 1.0 million active physicians (US, 2024) to fill local gaps and support referral lines. Nurses, advanced practice providers, and allied staff—part of a 3.1 million registered nurse workforce (US, 2024)—deliver daily operations and throughput. Medical leadership establishes clinical standards, protocols and quality metrics tied to reimbursement and readmission rates. Credentialed networks preserve community access breadth through hospital affiliations and payer contracts.
EHRs, PACS, RCM and analytics platforms underpin CHS operations, with certified EHRs used by about 96% of U.S. hospitals to streamline workflows; interoperability enables care coordination and population health management across networks. Data warehouses drive performance measurement and payer contracting insights, while cybersecurity tools mitigate risk—healthcare data breaches averaged a $10.1M cost in 2023 per IBM.
Brand, licenses, and payer contracts
Local brand recognition drives patient choice in community markets, with loyalty and referrals key to volume and outpatient growth.
State licenses, accreditations, and certifications define permissible service scope and reimbursement eligibility across sites of care.
Payer contracts set rates, steerage and value-based incentives; 340B participation (over 11,000 entities in 2024) improves pharmacy margins where applicable.
- Local brand: patient choice, referral retention
- Licenses: service scope, reimbursement
- Payer contracts: rates, steerage, value incentives
- 340B 2024: >11,000 participants, pharmacy margin lift
Capital and real estate
Access to diversified debt and equity facilities funds CHS investments and EMR/diagnostic technology upgrades; 2024 net revenue was about $11.4B supporting capital programs.
Real estate holdings across ~70 hospitals grant strategic site control; equipment fleets enable high‑acuity care and advanced diagnostics while asset management reduces lifecycle costs and boosts utilization.
- Hospitals: ~70
- 2024 revenue: $11.4B
- Focus: EMR, diagnostics, fleet uptime
CHS key resources: ~70 hospitals, outpatient sites and EDs capture volume (US ED visits ~130M); workforce of physicians and 3.1M RNs supports care; tech stack (EHR, RCM, analytics) enables coordination; payer contracts, 340B (>11,000 participants) and $11.4B 2024 revenue fund capital and operations.
| Metric | 2024 |
|---|---|
| Hospitals | ~70 |
| Revenue | $11.4B |
| US ED visits | ~130M |
| 340B participants | >11,000 |
Value Propositions
Provide comprehensive services close to home—CHS’s network of about 85 hospitals keeps ED and essential services open in non-urban markets, reducing travel burdens (average rural travel >30 miles) and lowering avoidable admissions; targeted programs (chronic disease management, telehealth) improved care coordination and supported financial stability, contributing to CHS’s roughly $12B revenue scale in 2024 while driving better community outcomes.
Seamless inpatient-to-outpatient transitions reduce readmissions and shorten length of stay, lowering exposure to CMS Hospital Readmissions Reduction Program penalties of up to 3% of Medicare payments. Strong outpatient and post-acute linkages improve recovery trajectories and reduce costly returns. Unified records enhance safety and patient experience, while coordinated scheduling simplifies journeys and boosts throughput.
Standardized protocols such as the WHO Surgical Safety Checklist have been shown to cut complications by up to 36% and mortality by up to 47%, driving consistent outcomes. Investment in staff training and technologies like CPOE and barcode medication administration reduces medication errors by over 50%, elevating safety. Performance transparency via public reporting correlates with higher patient trust and market share, while continuous improvement programs lower complication rates and operating costs.
Specialty service line depth
Cardiac, orthopedic, surgical and women’s health lines align with regional demand, supporting high-acuity volumes and revenue diversification; advanced diagnostics (CT/MRI/echo) enable faster decisions and reduced LOS. Telehealth now augments specialist access with expanded coverage and continuity of care. Multi-disciplinary teams coordinate complex cases, lowering readmissions and improving throughput.
Cost-effective care and value alignment
Competitive pricing and efficient operations lower payor and employer spend, improving margins while addressing US health spending of about $4.5 trillion in 2023. Value-based contracts reward outcomes and lower total cost per member. 340B and supply-chain scale reduce input costs and patients receive financial counseling and transparent billing.
- Cost savings: lower unit costs and negotiated discounts
- Value-based: outcome-linked payments, reduced TCO
- Supply leverage: 340B and bulk procurement
- Patient support: counseling and price transparency
CHS delivers near-home comprehensive care via ~85 hospitals, supporting $12B revenue in 2024 and reducing rural travel burdens (>30 miles). Integrated inpatient–outpatient pathways cut readmissions risk (CMS penalties up to 3%) and shorten LOS; safety protocols (WHO checklist, CPOE) lower complications (~36%) and med errors (>50%). Telehealth and specialty lines (cardiac, ortho, women’s) expand access and diversify revenue.
| Metric | 2024/Source | Impact |
|---|---|---|
| Hospitals | ~85 | Market presence |
| Revenue | $12B (2024) | Scale |
| Readmission penalty | Up to 3% | Cost risk |
Customer Relationships
Care managers and navigators guide patients across settings, with discharge planning that directly links to post-acute providers to reduce fragmentation; transitional-care interventions have cut readmissions by up to 25% (Cochrane 2020) while CMS reports a ~15.7% national 30-day readmission rate (2023); standardized follow-up protocols boost adherence and satisfaction, and closed-loop e-referrals raise successful follow-up rates to >80% in high-performing systems (2022).
Health fairs, screenings and education build trust and connect residents to care while identifying unmet needs early. Partnerships tackle social determinants—housing, food and transport—which influence roughly 30–55% of health outcomes. Public communications boost preparedness and prevention efforts. Federally funded community health centers are governed by patient-majority local boards that shape services.
Patient portals, online scheduling, and billing self-service streamline access and can cut no-show rates by up to 30% while improving collections; portal adoption reached roughly 65% of patients by 2024. Multilingual navigation and financial counseling reduce friction and uncompensated care, with financial navigation programs boosting collections by low-double digits. Continuous feedback loops enable rapid service recovery and reduce complaints, and enhanced amenities/hospitality correlate with HCAHPS gains of several points.
Physician relations and liaison programs
Physician relations and liaison programs use regular touchpoints to strengthen referral patterns and support co-management, CME collaboration, and secure data sharing to add clinical and revenue value. Issue resolution and streamlined onboarding accelerate integration and reduce leakage. Dashboards tracking referral volume, conversion and time-to-onboard support joint planning; AAMC projects physician shortages up to 124,000 by 2034.
- Regular touchpoints: strengthens referrals
- CME/co-management/data: adds value
- Issue resolution/onboarding: faster integration
- Performance dashboards: enable joint planning
Employer and payor account management
Care managers, portals and navigator-led transitions cut fragmentation and readmissions (transitional care − up to 25% Cochrane 2020) amid a 15.7% national 30‑day readmission rate (CMS 2023). Portal adoption reached ~65% by 2024 and can lower no-shows ~30%. Employer premiums (~$23,000 family, KFF 2024) drive direct-to-employer deals and narrow networks; physician shortfall risk (≈124,000 by 2034, AAMC) stresses partnerships.
| Metric | Value | Source |
|---|---|---|
| 30‑day readmission | 15.7% | CMS 2023 |
| Transitional-care effect | −up to 25% | Cochrane 2020 |
| Portal adoption | ≈65% | 2024 |
| Employer family premium | $23,000 | KFF 2024 |
| Physician shortage | ≈124,000 by 2034 | AAMC |
Channels
Emergency departments and urgent care serve as high-visibility access points, capturing acute demand—US EDs logged about 131 million visits in 2024 (CDC provisional). Robust triage pathways funnel patients to observation, primary care, or admission, reducing inappropriate admissions by up to 20%. ED-initiated follow-up drives downstream specialty visits and revenue; post-ED referral rates often exceed 30%. Local presence strengthens community brand and patient retention.
Liaisons plus shared EHR connectivity streamline referrals, leveraging EHR adoption levels above 90% in US hospitals to reduce handoffs; specialist clinics actively coordinate care plans with primary care using shared workflows; referral-management tools quantify and reduce leakage through tracking and analytics; joint marketing funds co-branded service lines, improving referral volume and service-line ROI in integrated networks.
Online scheduling, patient portals and virtual visits expand access—telehealth comprised about 10–15% of outpatient encounters in 2024, boosting bookings and reach. Digital triage plus automated reminders cut no-shows by 20–40%. Tele-specialty closes rural gaps, avoiding median 50+ mile travel. Analytics enable targeted outreach and lift retention.
Outpatient clinics and ASCs
Outpatient clinics and ASCs deliver convenient, lower-cost care—ASCs numbered about 6,000 in the US in 2024 and typically have facility fees ~40% below hospital outpatient departments; pre- and post-op pathways such as enhanced recovery reduce length of stay and cancellations by roughly 25–30%, while extended evening/weekend hours can boost access and visit volume by ~15%.
- Cost: ASCs ~40% lower facility fees (2024)
- Scale: ~6,000 ASCs in US (2024)
- Pathways: ERAS cuts LOS/cancellations ~25–30%
- Diagnostics: onsite imaging/labs cut TAT to <24 hrs
- Access: extended hours ↑ visits ~15%
Community and employer partnerships
Onsite screenings and wellness events drive measurable engagement, with employer health fairs in 2024 reporting average participation rates around 18% and a 10% uptick in preventive service use; employer coalitions steer members to in-network care, lowering average claim costs by several percent. Public health collaborations and local media campaigns amplified reach, increasing awareness and appointment bookings across communities.
- Participation ~18% (2024)
- Preventive uptake +10%
- In-network steering reduces claims ~several %
- Media/PH partnerships boost bookings
EDs/urgent care capture acute demand (131M US visits, 2024) and drive >30% post-ED referrals; robust triage cuts inappropriate admissions ~20%. EHR connectivity (>90% adoption) and liaison-led referrals reduce leakage; telehealth (10–15% outpatient mix, 2024) cuts no-shows 20–40% and closes rural gaps. ASCs (~6,000, 2024) offer ~40% lower facility fees; employer screenings lift preventive use +10% (participation ~18%).
| Channel | Key metric (2024) | Impact |
|---|---|---|
| ED/Urgent Care | 131M visits | >30% referrals; −20% inappropriate admissions |
| EHR/Referrals | >90% adoption | Reduced handoffs, lower leakage |
| Telehealth | 10–15% outpatient mix | No-shows −20–40%; rural access ↑ |
| ASCs | ~6,000; fees −40% | Lower cost, +15% extended-hours volume |
| Employer outreach | Participation 18% | Preventive uptake +10% |
Customer Segments
Patients seeking acute, surgical, and outpatient services in non-urban and select urban markets prioritize proximity and timely access. Clinical acuity spans routine to complex care, requiring scalable capabilities. Financial profiles vary across commercial, Medicare, Medicaid, and uninsured payor types. About 46 million Americans (14%) live in nonmetropolitan counties (US Census Bureau), shaping demand.
Medicare and Medicaid drive significant volume—Medicare enrolled ~64 million beneficiaries in 2024 and Medicaid/CHIP covered roughly 83 million, representing a large payer base and budget leverage. Commercial insurers prioritize value-based contracts and network integrity to control costs. Managed care entities focus on measurable outcomes and utilization management. TPAs and Medicare Advantage plans actively manage steerage and network referrals to optimize spend.
Regional employers and benefit managers prioritize cost control and productivity, with average 2024 employer-sponsored health premiums at about $8,000 single and $23,000 family annually, driving interest in value-based solutions. Direct contracting and Centers of Excellence for select procedures reduce unit costs and referral leakage. Integrated wellness and occupational health programs address absenteeism and presenteeism. Robust claims and outcomes reporting informs benefits strategy and ROI.
Physicians and provider partners
Post-acute and community organizations
SNFs, inpatient rehab, and home health coordinate transitions to lower 30-day readmissions—collaborative discharge models have reduced readmissions by up to 20% in recent studies; SNF occupancy hovered near 72% in 2023–24 while Medicare home health spending reached about $113B in 2023. Community organizations target prevention and social needs, and mutual referrals between post-acute providers and community groups improve occupancy and patient outcomes. Joint chronic-disease programs (heart failure, COPD, diabetes) have cut avoidable hospitalizations by roughly 10–15% in real-world pilots.
- Post-acute partners: SNFs, inpatient rehab, home health
- Outcome lift: readmissions down ~20%
- Financial scale: Medicare home health ~$113B (2023)
- Occupancy: SNFs ~72% (2023–24)
- Chronic care programs: hospitalizations down ~10–15%
Patients in nonurban/select urban markets prioritize proximity and timely access; ~46 million Americans (14%) live in nonmetropolitan counties (US Census Bureau). Medicare ~64 million beneficiaries (2024) and Medicaid/CHIP ~83 million (2024) drive volume and payment mix. Employer premiums avg ~$8,000 single / ~$23,000 family (2024); outpatient surgery >60% of procedures (2023–24).
| Metric | Value |
|---|---|
| Nonmetro population | 46M (14%) |
| Medicare | ~64M (2024) |
| Medicaid/CHIP | ~83M (2024) |
| Employer premiums | $8K single / $23K family (2024) |
| Outpatient surgery | >60% (2023–24) |
Cost Structure
Labor drives the largest expense for CHS, accounting for roughly half of hospital operating costs (AHA 2023), with registered nurse mean wages at about $88,090 per year (BLS May 2023). Salaries, benefits and costly agency labor—often 2x base rates for short-term coverage—push overall payroll spend higher. Recruitment, training and retention programs add recurring overhead, and overtime/premium pay can inflate margins by double-digit percentages during staffing shortages. Workforce optimization is essential to balance clinical quality and cost.
High-cost medical supplies, implants and pharmaceuticals can drive 20–40% of per-procedure costs; implant margins often determine procedural profitability. GPO leverage and formulary controls typically reduce supply/drug spend by roughly 8–15% in 2024. 340B pricing can deliver up to ~50% discounts where eligible. Robust inventory and wastage management programs can cut supply spend another 3–6% while preserving case availability.
Utilities, maintenance and depreciation drive roughly 30% of facility fixed costs, with annual energy spend often a top-5 line item; equipment upgrades and expansions require dedicated capex—commonly 5–10% of revenue in capital-intensive firms in 2024—and lease obligations can lock 10–15% of operating cash flow, reducing flexibility; targeted energy and sustainability initiatives have cut run-rate by 8–18% in recent 2024 industry case studies.
IT systems, cybersecurity, and licensing
EHR upkeep, RCM platforms and interfaces carry recurring fees—EHR maintenance often runs 15–20% of license costs annually, while RCM vendors charge per-claim fees (commonly 3–6%) or subscription tiers. Cybersecurity investments are critical: IBM's 2023 Cost of a Data Breach reported an average breach cost of $4.45M, pushing higher 2024 security budgets. Software licenses, connectivity, data compliance and audits create steady annual operating costs.
- EHR maintenance: 15–20% of license/year
- RCM: 3–6% per claim or subscription fees
- Avg breach cost (IBM 2023): $4.45M → higher 2024 security spend
- Compliance/audits: recurring budget line
Insurance, compliance, and administrative
Malpractice and liability premiums are material, representing roughly 1–3% of operating expenses for US health systems in 2024; catastrophic legal reserves have kept actuarial costs elevated. Regulatory compliance requires dedicated teams to manage CMS, HIPAA, and state licensure updates, often 2–4% of FTEs. Corporate functions cover finance, HR, and legal, while marketing and community outreach add incremental overhead near 0.5–1% of budget.
- Malpractice/liability: 1–3% of operating expenses (2024)
- Compliance teams: 2–4% of FTEs
- Marketing/outreach: 0.5–1% of budget
Labor (~50% of operating costs; RN mean wage $88,090, BLS May 2023), supplies/drugs (20–40% per-procedure; GPO savings 8–15%; 340B up to 50%), facilities/capex (~30% fixed costs; capex 5–10% revenue), IT/security/RCM (EHR maintenance 15–20% license; RCM 3–6%/claim; avg breach cost $4.45M IBM 2023).
| Line | 2024 metric |
|---|---|
| Labor | ~50% |
| Supplies/Drugs | 20–40% |
| Capex | 5–10% rev |
Revenue Streams
Admissions generate DRG or per-diem reimbursement—average Medicare DRG payment per discharge was roughly $14,000 in 2024, with total inpatient DRG revenue forming the majority of acute-care receipts. Case mix index and length of stay drive yield, while quality programs adjust net payments by about ±2–3% under CMS value-based rules. Outlier payments cover exceptionally high-cost stays above the ~$38,000 fixed-loss threshold, cushioning high-acuity case margins.
APCs and fee-for-service remain the primary payment drivers for clinics and ASCs under Medicare's 2024 outpatient prospective payment system, with imaging, labs and same-day surgeries forming core revenue lines. Higher throughput and lower per-case costs boost ASC margins versus inpatient settings. Preventive and diagnostic visit volumes provide stable baseline demand, smoothing seasonal swings and supporting capacity planning.
ED professional and facility fees are core revenue drivers for CHS, while ancillaries—therapy, imaging and pharmacy—typically contribute materially to per‑visit margins; observation stays can shift volumes and revenue between inpatient and outpatient settings. Uncompensated care remains significant, with U.S. hospitals providing roughly $40 billion in uncompensated care in recent years, partially offset by DSH and state subsidies.
Physician services and professional fees
Employed physician groups bill evaluation and management and procedural CPT codes; 2024 billing practices continue to drive professional revenue for CHS. Co-management contracts and call stipends provide stable incremental income; hospitalist and intensivist programs improve continuity and throughput. Participation in 2024 shared-savings arrangements can further augment earnings.
- Billed codes: E/M + procedure revenue
- Co-management & call stipends
- Hospitalist/intensivist continuity
- Shared savings participation 2024
Value-based, risk, and other contracts
CHS leverages value-based, risk, and other contracts where shared savings, bundled payments, and pay-for-performance can add 5–15% upside to service margins; 2024 MSSP-like programs returned roughly $1.2B in shared savings to participants. Direct-to-employer deals create steerage and fixed case rates, while 340B and drug rebates contributed about $17B in program discounts nationwide in 2024. Leasing, JVs, and management fees further diversify non-patient income streams and stabilize cash flow.
- Shared savings/P4P: margin upside 5–15%
- Bundles/case rates: predictable revenue
- Direct-to-employer: steerage + case rates
- 340B/rebates: ~$17B (2024)
- Leases/JVs/management fees: diversified income
Admissions (Medicare DRG avg ~$14,000/discharge in 2024) and outpatient APCs/ASC cases drive core patient revenue; quality adjustments ±2–3% and outlier payments (loss threshold ~$38,000) affect net yield. Uncompensated care (~$40B U.S.) and 340B/drug rebates (~$17B, 2024) materially impact margins, while MSSP/shared savings (~$1.2B returned in 2024) and direct-to-employer deals add upside.
| Metric | 2024 Value |
|---|---|
| Medicare DRG avg | $14,000 |
| Outlier threshold | $38,000 |
| Uncompensated care (US) | $40B |
| 340B/rebates | $17B |
| MSSP shared savings | $1.2B |